Nutex Health Inc (NUTX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.02 is considered Undervalued compared with the five-year average of -23.37. The fair price of Nutex Health Inc (NUTX) is between 125.52 to 174.44 according to relative valuation method. Compared to the current price of 117.60 USD , Nutex Health Inc By Undervalued By 6.31%.

Relative Value

Fair Zone

125.52-174.44

Current Price：117.60

6.31%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Nutex Health Inc (NUTX) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Nutex Health Inc (NUTX) has a current Price-to-Book (P/B) ratio of 3.23. Compared to its 3-year average P/B ratio of 2.61, the current P/B ratio is approximately 23.84% higher. Relative to its 5-year average P/B ratio of 5.80, the current P/B ratio is about -44.34% higher. Nutex Health Inc (NUTX) has a Forward Free Cash Flow (FCF) yield of approximately 16.63%. Compared to its 3-year average FCF yield of 6.49%, the current FCF yield is approximately 156.39% lower. Relative to its 5-year average FCF yield of 6.20%, the current FCF yield is about 168.42% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NUTX competitors is 2.72, providing a benchmark for relative valuation. Nutex Health Inc Corp (NUTX.O) exhibits a P/S ratio of 1.02, which is -62.41% above the industry average. Given its robust revenue growth of 239.87%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NUTX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NUTX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NUTX currently overvalued or undervalued?

What is Nutex Health Inc (NUTX) fair value?

NUTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Nutex Health Inc (NUTX) is between 125.52 to 174.44 according to relative valuation method.

How does NUTX's valuation metrics compare to the industry average?

The average P/S ratio for NUTX's competitors is 2.72, providing a benchmark for relative valuation. Nutex Health Inc Corp (NUTX) exhibits a P/S ratio of 1.02, which is -62.41% above the industry average. Given its robust revenue growth of 239.87%, this premium appears sustainable.

What is the current P/B ratio for Nutex Health Inc (NUTX) as of Mar 02 2026?

As of Mar 02 2026, Nutex Health Inc (NUTX) has a P/B ratio of 3.23. This indicates that the market values NUTX at 3.23 times its book value.

What is the current FCF Yield for Nutex Health Inc (NUTX) as of Mar 02 2026?

As of Mar 02 2026, Nutex Health Inc (NUTX) has a FCF Yield of 16.63%. This means that for every dollar of Nutex Health Inc's market capitalization, the company generates 16.63 cents in free cash flow.

What is the current Forward P/E ratio for Nutex Health Inc (NUTX) as of Mar 02 2026?

As of Mar 02 2026, Nutex Health Inc (NUTX) has a Forward P/E ratio of 8.47. This means the market is willing to pay $8.47 for every dollar of Nutex Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Nutex Health Inc (NUTX) as of Mar 02 2026?

As of Mar 02 2026, Nutex Health Inc (NUTX) has a Forward P/S ratio of 1.02. This means the market is valuing NUTX at $1.02 for every dollar of expected revenue over the next 12 months.

NUTX Valuation